{"title":"Choroidal thickness and peripapillary RNFL in relation to axial length and progression in myopic children.","authors":"Zixun Wang, Xiaoxue Hu, Xiaoling Zhang, Yuhang Wang, Zhiqing Li, Zheng Guo","doi":"10.3389/fbioe.2026.1777062","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Axial length (AL) elongation is a key structural hallmark of myopia progression in children. Identifying early ocular structural characteristics associated with AL growth may help improve risk stratification, although robust predictive models remain limited.</p><p><strong>Purpose: </strong>To explore cross-sectional associations between baseline ocular structural parameters and AL, and to preliminarily evaluate the predictive potential of these parameters for rapid AL progression in myopic children.</p><p><strong>Methods: </strong>A total of 463 myopic children were retrospectively followed for 1 year. Baseline assessments included cycloplegic refraction, ocular biometry, and optical coherence tomography (OCT)-derived measurements of choroidal thickness (ChT) and retinal nerve fiber layer (RNFL). Rapid AL progression was defined as an AL increase of >0.2 mm over 1 year. Cross-sectional correlations between baseline AL, ChT, and RNFL parameters were analyzed. Least absolute shrinkage and selection operator (Lasso) regression with 10-fold cross-validation was used for feature selection, followed by the development and validation of a logistic regression model. Model performance was assessed using the area under the receiver operating characteristic curve (AUC), calibration analysis, and decision curve analysis (DCA).</p><p><strong>Results: </strong>At baseline, AL showed significant cross-sectional associations with ChT and multiple RNFL parameters, with the strongest correlations observed for ChT and nasal-inferior RNFL thickness (RNFL[NI]). Lasso regression retained age, baseline AL, ChT, and RNFL[NI] as candidate predictors of rapid AL progression. In the validation set, the final model demonstrated modest discriminative performance (AUC = 0.703, 95% CI: 0.598-0.801) with acceptable calibration. Decision curve analysis indicated limited but consistent net clinical benefit across a range of threshold probabilities.</p><p><strong>Conclusion: </strong>This study provides exploratory evidence that posterior segment structural parameters are associated with AL and may be useful for predicting subsequent AL progression in myopic children. Although the model's predictive performance was modest, the findings support the hypothesis that OCT-derived biomarkers could contribute to future risk-stratification strategies, warranting further validation and refinement.</p>","PeriodicalId":12444,"journal":{"name":"Frontiers in Bioengineering and Biotechnology","volume":"14 ","pages":"1777062"},"PeriodicalIF":4.8000,"publicationDate":"2026-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13143951/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Bioengineering and Biotechnology","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.3389/fbioe.2026.1777062","RegionNum":3,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Axial length (AL) elongation is a key structural hallmark of myopia progression in children. Identifying early ocular structural characteristics associated with AL growth may help improve risk stratification, although robust predictive models remain limited.
Purpose: To explore cross-sectional associations between baseline ocular structural parameters and AL, and to preliminarily evaluate the predictive potential of these parameters for rapid AL progression in myopic children.
Methods: A total of 463 myopic children were retrospectively followed for 1 year. Baseline assessments included cycloplegic refraction, ocular biometry, and optical coherence tomography (OCT)-derived measurements of choroidal thickness (ChT) and retinal nerve fiber layer (RNFL). Rapid AL progression was defined as an AL increase of >0.2 mm over 1 year. Cross-sectional correlations between baseline AL, ChT, and RNFL parameters were analyzed. Least absolute shrinkage and selection operator (Lasso) regression with 10-fold cross-validation was used for feature selection, followed by the development and validation of a logistic regression model. Model performance was assessed using the area under the receiver operating characteristic curve (AUC), calibration analysis, and decision curve analysis (DCA).
Results: At baseline, AL showed significant cross-sectional associations with ChT and multiple RNFL parameters, with the strongest correlations observed for ChT and nasal-inferior RNFL thickness (RNFL[NI]). Lasso regression retained age, baseline AL, ChT, and RNFL[NI] as candidate predictors of rapid AL progression. In the validation set, the final model demonstrated modest discriminative performance (AUC = 0.703, 95% CI: 0.598-0.801) with acceptable calibration. Decision curve analysis indicated limited but consistent net clinical benefit across a range of threshold probabilities.
Conclusion: This study provides exploratory evidence that posterior segment structural parameters are associated with AL and may be useful for predicting subsequent AL progression in myopic children. Although the model's predictive performance was modest, the findings support the hypothesis that OCT-derived biomarkers could contribute to future risk-stratification strategies, warranting further validation and refinement.
期刊介绍:
The translation of new discoveries in medicine to clinical routine has never been easy. During the second half of the last century, thanks to the progress in chemistry, biochemistry and pharmacology, we have seen the development and the application of a large number of drugs and devices aimed at the treatment of symptoms, blocking unwanted pathways and, in the case of infectious diseases, fighting the micro-organisms responsible. However, we are facing, today, a dramatic change in the therapeutic approach to pathologies and diseases. Indeed, the challenge of the present and the next decade is to fully restore the physiological status of the diseased organism and to completely regenerate tissue and organs when they are so seriously affected that treatments cannot be limited to the repression of symptoms or to the repair of damage. This is being made possible thanks to the major developments made in basic cell and molecular biology, including stem cell science, growth factor delivery, gene isolation and transfection, the advances in bioengineering and nanotechnology, including development of new biomaterials, biofabrication technologies and use of bioreactors, and the big improvements in diagnostic tools and imaging of cells, tissues and organs.
In today`s world, an enhancement of communication between multidisciplinary experts, together with the promotion of joint projects and close collaborations among scientists, engineers, industry people, regulatory agencies and physicians are absolute requirements for the success of any attempt to develop and clinically apply a new biological therapy or an innovative device involving the collective use of biomaterials, cells and/or bioactive molecules. “Frontiers in Bioengineering and Biotechnology” aspires to be a forum for all people involved in the process by bridging the gap too often existing between a discovery in the basic sciences and its clinical application.